Gastrointestinal stromal tumors: who should get imatinib and for how long?
about
Targeted therapy of gastrointestinal stromal tumoursRetrospective analysis of 85 cases of intermediate-risk gastrointestinal stromal tumor.How best to manage gastrointestinal stromal tumor.Retrospective study of laparoscopic versus open gastric resection for gastric gastrointestinal stromal tumors based on the propensity score matching method.Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies.Genomics of adult and pediatric solid tumors
P2860
Gastrointestinal stromal tumors: who should get imatinib and for how long?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Gastrointestinal stromal tumors: who should get imatinib and for how long?
@en
type
label
Gastrointestinal stromal tumors: who should get imatinib and for how long?
@en
prefLabel
Gastrointestinal stromal tumors: who should get imatinib and for how long?
@en
P2860
P1433
P1476
Gastrointestinal stromal tumors: who should get imatinib and for how long?
@en
P2093
Ronald P DeMatteo
Vinod P Balachandran
P2860
P304
P356
10.1016/J.YASU.2014.05.014
P577
2014-01-01T00:00:00Z